Fatal cutaneous mucormycosis after kidney transplant

Experimental and Clinical Transplantation

Volumn 13, Issue 1, 2015, Pages 82-85

  Davuodi, Setareh ^a   Manshadi, Seyed Ali Dehghan ^a   Salehi, Mohammad Reza ^a   Yazdi, Farhad ^a   Khazravi, Mona ^a   Fazli, Jafar Taghizade ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Complications; Fungus; Immunosuppression; Infection; Skin

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CIPROFLOXACIN; IMIPENEM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; VANCOMYCIN; ANTIINFECTIVE AGENT; IMMUNOSUPPRESSIVE AGENT;

AGED; ARTICLE; CASE REPORT; CUTANEOUS MUCORMYCOSIS; DEBRIDEMENT; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; END STAGE RENAL DISEASE; FEVER; FUNGUS HYPHAE; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY GRAFT; MALE; MEDICAL HISTORY; MUCORMYCOSIS; SEPTIC SHOCK; SKIN BIOPSY; SKIN NECROSIS; SURGICAL INFECTION; SURGICAL RISK; ADVERSE EFFECTS; BIOPSY; DERMATOMYCOSES; FATALITY; IMMUNOCOMPROMISED PATIENT; KIDNEY TRANSPLANTATION; MICROBIOLOGY; SURGICAL WOUND INFECTION; TIME FACTOR; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BIOPSY; DEBRIDEMENT; DERMATOMYCOSES; FATAL OUTCOME; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MUCORMYCOSIS; SHOCK, SEPTIC; SURGICAL WOUND INFECTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84922031907     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: 10.6002/ect.2013.0216     Document Type: Article

References (12)

1. Kerbaul F, Guidon C, Collart F, et al. Abdominal wall mucormycosis after heart transplantation. J Cardiothorac Vasc Anesth. 2004;18(6): 822-823.
2. Zirak C, Brutus JP, De Mey A. Atypical cause of forearm skin ulceration in a leukaemic child: mucormycosis. A case report. Acta Chir Belg. 2005;105(5):551-553.
3. Becker BC, Schuster FR, Ganster B, Seidl HP, Schmid I. Cutaneous mucormycosis in an immunocompromised patient. Lancet Infect Dis. 2006;6(8):536.
4. Arnáiz-García ME, Alonso-Peña D, González-Vela Mdel C, García-Palomo JD, Sanz-Giménez-Rico JR, Arnáiz-García AM. Cutaneous mucormycosis: report of five cases and review of the literature. J Plast Reconstr Aesthet Surg. 2009;62(11):e434-e441.
5. Flagothier C, Arrese JE, Quatresooz P, Pierard GE. Cutaneous mucormycosis [in French]. Journal de Mycologie Médicale. 2006;16 (2):77-81.
6. Godara SM, Kute VB, Goplani KR, et al. Mucormycosis in renal transplant recipients: predictors and outcome. Saudi J Kidney Dis Transpl. 2011;22(4):751-756.
7. Grossklaus DJ, Dutta SC, Shappel S, Kirchner FK. Cutaneous mucormycosis presenting as a penile lesion in a patient with acute myeloblastic leukemia. J Urol. 1999; 161(6):1906-1907.
8. Rammaert B, Lanternier F, Zahar JR, et al. Healthcare-associated mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S44-S54.
9. Page AV, Evans AJ, Snell L, Liles WC. Primary cutaneous mucormycosis in a lung transplant recipient: case report and concise review of the literature. Transpl Infect Dis. 2008;10(6):419-425.
10. Walsh TJ, Gamaletsou MN, McGinnis MR, Hayden RT, Kontoyiannis DP. Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary and disseminated mucormycosis (zygomycosis). Clin Infect Dis. 2012;54(Suppl 1):S55-S60.
11. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S23-S34
12. Lineberry KD, Boettcher AK, Blount AL, Burgess SD. Cutaneous mucormycosis of the upper extremity in an immunocompetent host: case report. J Hand Surg Am. 2012;37(4):787-791.